[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Liver Disease Treatment Market Report 2018

February 2018 | 98 pages | ID: U1DFFDBCD7DEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Liver Disease Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Liver Disease Treatment in these regions, from 2013 to 2025 (forecast).
United States Liver Disease Treatment market competition by top manufacturers/players, with Liver Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Gilead Science
  • Bayer AG
  • AstraZeneca
  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Pfizer
  • F. Hoffmann-La Roche
  • Novartis AG
  • Johnson &Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Anti-Rejection Drugs/Immunosupressants
  • Chemotherapy Drugs
  • Targeted therapy
  • Vaccines
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Adult
  • Children
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Liver Disease Treatment Market Report 2018

1 LIVER DISEASE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Liver Disease Treatment
1.2 Classification of Liver Disease Treatment by Product Category
  1.2.1 United States Liver Disease Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Liver Disease Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Anti-Rejection Drugs/Immunosupressants
  1.2.4 Chemotherapy Drugs
  1.2.5 Targeted therapy
  1.2.6 Vaccines
  1.2.7 Others
1.3 United States Liver Disease Treatment Market by Application/End Users
  1.3.1 United States Liver Disease Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Adult
  1.3.3 Children
1.4 United States Liver Disease Treatment Market by Region
  1.4.1 United States Liver Disease Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Liver Disease Treatment Status and Prospect (2013-2025)
  1.4.3 Southwest Liver Disease Treatment Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Liver Disease Treatment Status and Prospect (2013-2025)
  1.4.5 New England Liver Disease Treatment Status and Prospect (2013-2025)
  1.4.6 The South Liver Disease Treatment Status and Prospect (2013-2025)
  1.4.7 The Midwest Liver Disease Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Liver Disease Treatment (2013-2025)
  1.5.1 United States Liver Disease Treatment Sales and Growth Rate (2013-2025)
  1.5.2 United States Liver Disease Treatment Revenue and Growth Rate (2013-2025)

2 UNITED STATES LIVER DISEASE TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Liver Disease Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Liver Disease Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Liver Disease Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Liver Disease Treatment Market Competitive Situation and Trends
  2.4.1 United States Liver Disease Treatment Market Concentration Rate
  2.4.2 United States Liver Disease Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Liver Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIVER DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Liver Disease Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Liver Disease Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Liver Disease Treatment Price by Region (2013-2018)

4 UNITED STATES LIVER DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Liver Disease Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Liver Disease Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Liver Disease Treatment Price by Type (2013-2018)
4.4 United States Liver Disease Treatment Sales Growth Rate by Type (2013-2018)

5 UNITED STATES LIVER DISEASE TREATMENT SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Liver Disease Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Liver Disease Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIVER DISEASE TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Gilead Science
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liver Disease Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Gilead Science Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer AG
  6.2.2 Liver Disease Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer AG Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca
  6.3.2 Liver Disease Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.2 Liver Disease Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Merck & Co
  6.5.2 Liver Disease Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck & Co Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.2 Liver Disease Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Liver Disease Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 F. Hoffmann-La Roche
  6.8.2 Liver Disease Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 F. Hoffmann-La Roche Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Novartis AG
  6.9.2 Liver Disease Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis AG Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Johnson &Johnson
  6.10.2 Liver Disease Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson &Johnson Liver Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 LIVER DISEASE TREATMENT MANUFACTURING COST ANALYSIS

7.1 Liver Disease Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liver Disease Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liver Disease Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liver Disease Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIVER DISEASE TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Liver Disease Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Liver Disease Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Liver Disease Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Liver Disease Treatment Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Liver Disease Treatment
Figure United States Liver Disease Treatment Market Size (K Units) by Type (2013-2025)
Figure United States Liver Disease Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Anti-Rejection Drugs/Immunosupressants Product Picture
Figure Chemotherapy Drugs Product Picture
Figure Targeted therapy Product Picture
Figure Vaccines Product Picture
Figure Others Product Picture
Figure United States Liver Disease Treatment Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Liver Disease Treatment by Application in 2017
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Liver Disease Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Liver Disease Treatment Sales (K Units) and Growth Rate (2013-2025)
Figure United States Liver Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Liver Disease Treatment Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Liver Disease Treatment Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Liver Disease Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Liver Disease Treatment Sales Share by Players/Suppliers
Figure 2017 United States Liver Disease Treatment Sales Share by Players/Suppliers
Figure United States Liver Disease Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Liver Disease Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Liver Disease Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Liver Disease Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Liver Disease Treatment Revenue Share by Players/Suppliers
Table United States Market Liver Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Liver Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Liver Disease Treatment Market Share of Top 3 Players/Suppliers
Figure United States Liver Disease Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Liver Disease Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Liver Disease Treatment Product Category
Table United States Liver Disease Treatment Sales (K Units) by Region (2013-2018)
Table United States Liver Disease Treatment Sales Share by Region (2013-2018)
Figure United States Liver Disease Treatment Sales Share by Region (2013-2018)
Figure United States Liver Disease Treatment Sales Market Share by Region in 2017
Table United States Liver Disease Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Liver Disease Treatment Revenue Share by Region (2013-2018)
Figure United States Liver Disease Treatment Revenue Market Share by Region (2013-2018)
Figure United States Liver Disease Treatment Revenue Market Share by Region in 2017
Table United States Liver Disease Treatment Price (USD/Unit) by Region (2013-2018)
Table United States Liver Disease Treatment Sales (K Units) by Type (2013-2018)
Table United States Liver Disease Treatment Sales Share by Type (2013-2018)
Figure United States Liver Disease Treatment Sales Share by Type (2013-2018)
Figure United States Liver Disease Treatment Sales Market Share by Type in 2017
Table United States Liver Disease Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Liver Disease Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Liver Disease Treatment by Type (2013-2018)
Figure Revenue Market Share of Liver Disease Treatment by Type in 2017
Table United States Liver Disease Treatment Price (USD/Unit) by Types (2013-2018)
Figure United States Liver Disease Treatment Sales Growth Rate by Type (2013-2018)
Table United States Liver Disease Treatment Sales (K Units) by Application (2013-2018)
Table United States Liver Disease Treatment Sales Market Share by Application (2013-2018)
Figure United States Liver Disease Treatment Sales Market Share by Application (2013-2018)
Figure United States Liver Disease Treatment Sales Market Share by Application in 2017
Table United States Liver Disease Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Liver Disease Treatment Sales Growth Rate by Application (2013-2018)
Table Gilead Science Basic Information List
Table Gilead Science Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Science Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Gilead Science Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Gilead Science Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Bayer AG Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Bayer AG Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure AstraZeneca Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure AstraZeneca Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Merck & Co Basic Information List
Table Merck & Co Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Merck & Co Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Merck & Co Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Sanofi Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Sanofi Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Pfizer Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Pfizer Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Novartis AG Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Novartis AG Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Johnson &Johnson Basic Information List
Table Johnson &Johnson Liver Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson &Johnson Liver Disease Treatment Sales Growth Rate (2013-2018)
Figure Johnson &Johnson Liver Disease Treatment Sales Market Share in United States (2013-2018)
Figure Johnson &Johnson Liver Disease Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Disease Treatment
Figure Manufacturing Process Analysis of Liver Disease Treatment
Figure Liver Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Liver Disease Treatment Major Players/Suppliers in 2017
Table Major Buyers of Liver Disease Treatment
Table Distributors/Traders List
Figure United States Liver Disease Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Liver Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Liver Disease Treatment Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Liver Disease Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Liver Disease Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Liver Disease Treatment Sales Volume (K Units) Forecast by Type in 2025
Table United States Liver Disease Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Liver Disease Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Liver Disease Treatment Sales Volume (K Units) Forecast by Application in 2025
Table United States Liver Disease Treatment Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Liver Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Liver Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Liver Disease Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories